Introducing Good Policies: A new charity promoting behaviour change interventions
Introducing Good Policies
I am excited to announce the launch of Good Policies, a new EA-aligned charity looking for the most cost-effective advocacy opportunities in global health, currently exploring starting new tobacco taxation campaigns in neglected regions. Good Policies is incubated under and developed in partnership with Charity Entrepreneurship.
The leading cause of preventable deaths in low and middle-income countries are non-communicable diseases, but designing cost-effective solutions can be challenging, as it often requires changing an individual’s behaviour over time [8]. Implementing certain public health policies at a state or national level can effectively change the behaviour of many people. Our aim is to systematically identify the most cost-effective policy windows, and then fund and provide technical assistance to new campaigns that advocate for evidence-based policies, starting with tobacco taxation.
Here, I aim to inform the EA community of my rationale for founding an organisation in the global health policy space, my plans for piloting to better understand the potential impact of this organisation, and where this effort could benefit from the resources of this community.
Why focus on noncommunicable diseases?
Noncommunicable diseases kill approximately 41 million people each year, which is about 71% of all deaths globally [1]. The four noncommunicable diseases with the greatest annual death toll are cardiovascular diseases (17.9M), cancers (9.0M), respiratory diseases (3.9M) and diabetes (1.6M) which between them account for about 80% of all premature noncommunicable disease deaths. These are all strongly linked to tobacco consumption [4].
The primary drivers of premature noncommunicable disease deaths are generally linked to behaviour, particularly unhealthy diets, physical activity, alcohol use and exposure to tobacco smoke [5][6]. Implementing policies at a national level that effectively change people’s choices can significantly reduce the premature death toll and improve the quality of life of the country’s citizens at scale.
Why Advocacy?
It is not surprising that changing systems is challenging, but there are multiple case studies of groups successfully advocating for better policies around tobacco control. For a relatively small amount of money, external actors can influence governments to implement policies that improve public health. This may be one of the reasons why GiveWell are building their capacity to investigate opportunities to influence government policy as outlined in a blog post earlier this year [2]. GiveWell spoke with Ms Yolanda Richardson from the Campaign for Tobacco-Free Kids about their work on tobacco control policy and have mentioned that they plan to or are in the process of investigating the cost-effectiveness of interventions related to tobacco control [3][7].
There are plenty of potential weaknesses to advocacy-based interventions compared to more direct interventions. One large concern we have is understanding the impact of organisations in this space. The gold standard for impact analysis is the randomised control trial (RCT). Unfortunately, it is difficult to effectively randomise with policy-based interventions as we are unable to control for the numerous factors that affect the impact of an advocacy effort. In fact, it is difficult to understand even the base rate of effectiveness of advocacy in this space, as there seems to be a selection bias in case studies (it is rare to read about unsuccessful campaigns).
Due to the all-or-nothing nature of lobbying, it is difficult to attribute impact properly, especially when there are multiple actors working towards a common goal. One approach to understanding our marginal contribution is selecting particularly neglected regions where there are no existing related campaigns but even then, it can still be difficult to determine how much your contributions sped up the policy being implemented.
Plan
In order to address some of these questions, Good Policies is roughly split between two tasks. The first is developing and working through its research agenda and the second is piloting a campaign for increased tobacco prices in Mongolia via taxation.
Research
Our research focuses on systematically identifying cost-effective policy windows. It seems as though there are certain times and regions where an additional campaign might be particularly valuable. We are currently developing our model to more reliably estimate the cost-effectiveness of different policy windows. We are planning on publishing a more detailed research agenda in the near future, as well as cost-effectiveness estimates for various policy windows and the models used to compute these estimates and the model that we used to make this.
Pilot
We are currently exploring the possibility of starting a tobacco taxation campaign in Mongolia, in collaboration with a local NGO (the National Cancer Council of Mongolia). We believe that this collaboration will be far more effective than working independently in this region. As there is no existing advocacy effort for increased tobacco taxes in this region (that we are aware of) it may be easier to establish our counterfactual impact more concretely than in regions with more actors. Mongolia also has a very high smoking prevalence and is not a priority country for any large donor interested in tobacco control which may mean it is disproportionately neglected.
In addition to impact, running the pilot will allow us to gather information to improve our model and make substantial progress on our research agenda. It is likely that in our current cost-effectiveness model we have neglected important factors that we think being up close during a policy window may highlight
Some of the key deliverables in the early stages of the pilot will be an expected cost-effectiveness analysis and a strategy for developing models that can be generalised to similar campaigns. If by our estimates our intervention looks less cost-effective than GiveWell’s current top charities then we will scale down operations and pivot to another intervention.
How you can help?
Hires
I am looking for a co-founder, ideally with experience lobbying LMIC governments or someone that can bring a similar skillset (see job description). I expect that I will also hire an operations lead and I have various internships on my website. All of these positions can be found here.
Advisors
I am also keen to find advisors who are happy to consult with us whilst we continue to develop our vision. If you have experience in starting organisations, public health or lobbying/advocacy I would love to connect with you.
Funding
I am also looking for funding in order to raise money for our pilot. I have a fundraising proposal on my website so if you, or someone you know, is excited about funding a new organisation in this space I would love to hear from you. Additionally, if you are not in a position to fundraise but think you are well-positioned to advise us on securing funding, I am keen to get as wide a perspective on this as possible.
Feedback
You can reach out to me directly to talk about any of the above or give feedback on the project at caleb.parikh@goodpolicies.org.
Good Policies was incubated under Charity Entrepreneurship, an effective altruism organization, which provided our initial funding.
References
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31679-8/fulltext
https://blog.givewell.org/2019/02/07/how-givewells-research-is-evolving/
https://files.givewell.org/files/conversations/Yolonda_Richardson_12-12-17_(public).pdf
https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
Hey, I was wondering if you had taken into account the consumer surplus from smoking in your estimates?
This might not be a small factor:
Many smokers report enjoying the experience of smoking.
Many people choose to smoke despite knowing about the health effects.
Newer forms of tobacco consumption, like vaping, have significantly lower health side-effects.
Rational choice is still possible in the presence of addiction—see for example Becker and Murphy (1988).
I think this is especially important because preventing people from smoking is much more coercive than most EA projects; typically we are helping people do something they either want to do anyway or are at worst indifferent (e.g. with GiveDirectly or Against Malaria Foundation). But taxing products that people want to consume (even if they might me ill-informed or the like) is quite different.
As a concrete example, the killing of Eric Garner by the NYPD, one of the causes of the Black Lives Matter Movement, was directly caused by (among other things) high tobacco taxation.
(I previously brought up this issue here)
Apologies for not replying to this earlier but thank you for posing your question.
I had a few thoughts on the points that you made about why consumer surplus might not be a small factor.
This may be true but I think these people are by far in the minority. Tobacco taxes do not target people who enjoy smoking but are of course applied to the whole population (assuming full compliance).
I am not entirely sure what this claim is based on. I think that this may well not be true and may be less relevant to this project for a few reasons.
1. The health effects can be hard to understand, partly because of the tobacco industry pushing pseudo-science to prevent tobacco control laws from being passed.
2. Even if people do fully understand the effect of addiction means that people keep choosing to smoke even if they want to quit. My understanding is that the majority of smoker do want to quit.
3. In many LMICs, I think this is an unreasonable expectation particularly when the tobacco industry pedals misinformation around the harmful effects of smoking and that many countries don’t have warnings on packages (unlike in the UK/USA).
So far the evidence does seem to point that way. There is still considerable debate around whether nicotine delivery systems are helpful or not (particularly in countries which aren’t equipped to regulate them) but generally, e-cig adoption is lesser in LMICs and tax structures can penalise more harmful products over lesser ones to encourage switching which would mitigate this risk.
I have not read through this paper fully but I have a few remarks for it’s applicability to tobacco control (please do let me know if you think I misunderstand the paper).
1. Tobacco taxes reduce the number of people who smoke partly by reducing the incentive for people to take up smoking. This paper seems to examine only the case where the person is already addicted and is choosing whether to go ‘cold turkey’ to quit not whether a person should become addicted. I think given the above points it is sensible to say that the higher expected value option in most cases is not to start smoking.
2. The paper states that “present-oriented individuals are potentially more addicted to harmful goods than future-oriented individuals” but does not seem to say that it is rational to give in to addiction, more that given people’s individual time preferences some people rationally become addicted to harmful products (e.g. people with a more myopic view who discount the future) and continue to use them. I don’t think this really makes a statement about whether this behaviour is good or bad in itself, more an explanation of how some but not necessarily all rational agents can exhibit addictive properties (under their definition of rationality).
It is probably also useful to mention the large number of people that experience problems due to second-hand smoke (where the consumer surplus argument probably would not apply).
I don’t believe that the killing of Eric Garner is really attributable to increased tobacco taxes. Even if it were I am not sure that similar cases are common enough to outweigh the huge number of lives saved by this tax.
I have given some thought to the consumer surplus but have not formally modelled this mostly because I think it would take a long time and I trying to focus my attention on our pilot. If you were to build a quantitative model in guesstimate or similar I would love to take a look!
Not posting this because I agree with it but rather because I think it’s one of the more influential econ papers actually dealing with the reality of addiction: Bernheim and Rangel 2004 those suffering from addiction have no control and are poorer (even then people of the same ex ante income), and for those not suffering from addiction it’s not obvious why they are irrational.
I think the conclusion is almost certainly wrong, but why it’s wrong is a bit subtle and hard to pin down, so I thought it might be a helpful thing to be aware of going into this. It’s published in the AER so it’s sort of an influential enhancement of Larks’s comment.
(Also full disclosure that Bernheim is my advisor. That mostly just makes me more perplexed by this paper.)
Thanks Zach – I think your link is broken
You can access here:
https://www.rnl.caltech.edu/publications/pdf/aer04addiction.pdf
I’m sure there’s a better document somewhere addressing these, but I’ll just quickly say that people tend to regret starting smoking tobacco and often want to stop, tobacco smoking reduces quality of life, and that smokers often support raising tobacco taxes if the money goes to addressing the (very expensive!) health problems caused by smoking (e.g. this sample, and I don’t think this pattern is unique). So I think bringing tobacco taxes in line with recommendations is good under most moral systems, even those which strongly prioritize autonomy—this is a situation where smokers seem to be straightforwardly stating that they’d rather not behave this way.
Eric Garner died because the police approached him on suspicion of selling illegal cigarettes and then killed him—I don’t think that’s realistically attributable to tobacco taxation.
Also nicotine has cognitive benefits: https://www.gwern.net/Nicotine
A very general remark on this: “There are plenty of potential weaknesses to advocacy-based interventions compared to more direct interventions. One large concern we have is understanding the impact of organisations in this space.”
Federally organized constituencies (Switzerland, US, etc) are a great thing for political scientists: you can compare the effect of policies or advocacy campaigns in different sub-national jurisdictions which are very similar. (Not sure whether this is of any help in your case, though).
PS: Just to add: fantastic initiative. Curious to hear how it’s developing!